Rare diseases
Investigational molecules
Locations
A Study of BMS-986517 for Adults with Advanced Solid Tumors to Test Safety and Find the Best Dose
SpainTesting WIN378 Safety and Effects in Adults with Moderate or Severe Asthma
SpainA Study of BMS-986504 with Drug Combination Compared to Placebo with Drug Combination in Patients with Advanced Non-Small Cell Lung Cancer Starting First Treatment
SpainStudy of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer
SpainA study comparing datopotamab deruxtecan with durvalumab versus datopotamab deruxtecan alone for patients with PDL1-negative metastatic triple-negative breast cancer
SpainStudy of axatilimab compared to standard therapy in children with chronic graft-versus-host disease who have previously received at least 2 treatments
SpainStudy of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients
SpainStudy of PF-07248144 and fulvestrant in adults with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer who had progression after CDK4/6 inhibitor therapy
SpainStudy of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment
SpainStudy comparing Sucrosomial Iron and ferric maltol treatment for women with iron deficiency
SpainStudy of PRAX-628 to evaluate safety and effectiveness in adults with epilepsy who have focal seizures or generalized tonic-clonic seizures
SpainStudy of trastuzumab deruxtecan with pembrolizumab versus platinum chemotherapy with pembrolizumab for patients with untreated HER2-positive non-small cell lung cancer
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
